279 related articles for article (PubMed ID: 11956030)
21. A phase II trial of paclitaxel and cisplatin in patients with advanced squamous-cell carcinoma of the esophagus.
Zhang X; Shen L; Li J; Li Y; Li J; Jin M
Am J Clin Oncol; 2008 Feb; 31(1):29-33. PubMed ID: 18376224
[TBL] [Abstract][Full Text] [Related]
22. Epirubicin and cisplatin in recurrent, metastatic or advanced carcinoma of the cervix.
Lorvidhaya V
Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():252-5. PubMed ID: 7661592
[TBL] [Abstract][Full Text] [Related]
23. Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-naïve patients with locally advanced or metastatic breast carcinoma.
Hsu C; Huang CS; Chao TY; Lu YS; Bu CF; Chen MM; Chang KJ; Cheng AL
Cancer; 2002 Nov; 95(10):2044-50. PubMed ID: 12412156
[TBL] [Abstract][Full Text] [Related]
24. First-line chemotherapy with 5-FU and platinum for advanced and recurrent cancer of the cervix: a phase II study.
Ghaemmaghami F; Behtash N; Yarandi F; Moosavi A; Modares M; Toogeh G; Khanafshar N
J Obstet Gynaecol; 2003 Jul; 23(4):422-5. PubMed ID: 12881087
[TBL] [Abstract][Full Text] [Related]
25. Carboplatin in combination with raltitrexed in recurrent and metastatic head and neck squamous cell carcinoma: A multicentre phase II study of the Gruppo Oncologico Dell'Italia Meridionale (G.O.I.M.).
Galetta D; Giotta F; Rosati G; Gebbia V; Manzione L; Di Bisceglie M; Borsellino N; Colucci G
Anticancer Res; 2005; 25(6C):4445-9. PubMed ID: 16334124
[TBL] [Abstract][Full Text] [Related]
26. Activity of interferon-alpha and isotretinoin in patients with advanced, refractory lymphoid malignancies.
Tsimberidou AM; Giles F; Romaguera J; Duvic M; Kurzrock R
Cancer; 2004 Feb; 100(3):574-80. PubMed ID: 14745875
[TBL] [Abstract][Full Text] [Related]
27. The outcome of advanced or recurrent non-squamous carcinoma of the uterine cervix after platinum-based combination chemotherapy.
Kastritis E; Bamias A; Efstathiou E; Gika D; Bozas G; Zorzou P; Sarris K; Papadimitriou C; Dimopoulos MA
Gynecol Oncol; 2005 Nov; 99(2):376-82. PubMed ID: 16051322
[TBL] [Abstract][Full Text] [Related]
28. A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil.
Hsu CH; Cheng AL; Hsu C; Yang CH; Lu YS; Lin CC; Bu CF; Yeh KH
Anticancer Res; 2002; 22(6B):3621-7. PubMed ID: 12552966
[TBL] [Abstract][Full Text] [Related]
29. Phase II trial of oral vinorelbine in combination with cisplatin followed by consolidation therapy with oral vinorelbine in advanced NSCLC.
Lena MD; Ramlau R; Hansen O; Lorusso V; Wagner L; Barni S; Cristovao MM; Huber R; Alberola V; Mitrovic M; Colin C; Gasmi J
Lung Cancer; 2005 Apr; 48(1):129-35. PubMed ID: 15777980
[TBL] [Abstract][Full Text] [Related]
30. Combination chemotherapy with cisplatin and bleomycin in advanced cervical cancer.
Bloch B; Nel CP; Kriel A; Atad J; Goldberg G
Cancer Treat Rep; 1984 Jun; 68(6):891-3. PubMed ID: 6203640
[TBL] [Abstract][Full Text] [Related]
31. Phase II study of a combination of cisplatin, all-trans-retinoic acid and interferon-alpha in squamous cell carcinoma: clinical results and pharmacokinetics.
Goncalves A; Camerlo J; Bun H; Gravis G; Genre D; Bertucci F; Resbeut M; Pech-Gourg F; Durand A; Maraninchi D; Viens P
Anticancer Res; 2001; 21(2B):1431-7. PubMed ID: 11396227
[TBL] [Abstract][Full Text] [Related]
32. A phase II evaluation of tirapazamine plus cisplatin in the treatment of recurrent platinum-sensitive ovarian or primary peritoneal cancer: a Gynecologic Oncology Group study.
Covens A; Blessing J; Bender D; Mannel R; Morgan M;
Gynecol Oncol; 2006 Mar; 100(3):586-90. PubMed ID: 16249022
[TBL] [Abstract][Full Text] [Related]
33. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.
Rao GG; Rogers P; Drake RD; Nguyen P; Coleman RL
Gynecol Oncol; 2005 Jan; 96(1):168-72. PubMed ID: 15589596
[TBL] [Abstract][Full Text] [Related]
34. S-1 plus cisplatin combination chemotherapy in patients with advanced non-small cell lung cancer: a multi-institutional phase II trial.
Ichinose Y; Yoshimori K; Sakai H; Nakai Y; Sugiura T; Kawahara M; Niitani H
Clin Cancer Res; 2004 Dec; 10(23):7860-4. PubMed ID: 15585618
[TBL] [Abstract][Full Text] [Related]
35. A phase II trial of cisplatin and vinorelbine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
Espinosa E; Zamora P; Millá A; Morales S; Molina R; Mira M; González Barón M;
Head Neck; 2002 Dec; 24(12):1054-9. PubMed ID: 12454943
[TBL] [Abstract][Full Text] [Related]
36. Bleomycin, mitomycin, and cisplatin therapy for advanced squamous carcinoma of the uterine cervix: a phase II study of the Northern California Oncology Group.
Picozzi VJ; Sikic BI; Carlson RW; Koretz M; Ballon SC
Cancer Treat Rep; 1985; 69(7-8):903-5. PubMed ID: 2410123
[TBL] [Abstract][Full Text] [Related]
37. [Combination chemotherapy with PAP (peplomycin, adriamycin and cisplatin) in recurrent uterine cervical cancer with pulmonary metastasis].
Fujii M; Okabe K; Toki H; Araki Y; Masaoka H
Gan To Kagaku Ryoho; 1984 Feb; 11(2):342-3. PubMed ID: 6198971
[TBL] [Abstract][Full Text] [Related]
38. Cis-platinum-adriamycin-cyclophosphamide in the treatment of advanced-recurrent cervical cancer.
Villalon AH; Lu-Lim JY; Esteba DV; Manalo A; Sotto L; Jimenez MV; Agustin BM
Southeast Asian J Trop Med Public Health; 1985 Dec; 16(4):660-4. PubMed ID: 3841763
[TBL] [Abstract][Full Text] [Related]
39. A phase II study of weekly paclitaxel and epirubicin in recurrent or refractory squamous cell carcinoma of the head and neck.
Wang TF; Chu SC; Kao RH; Yao CY; Li CC
Jpn J Clin Oncol; 2008 Jul; 38(7):459-63. PubMed ID: 18586668
[TBL] [Abstract][Full Text] [Related]
40. Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix: results of a phase II study.
Vrdoljak E; Prskalo T; Omrcen T; Situm K; Boraska T; Frleta Ilić N; Janković S; Hamm W
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):824-9. PubMed ID: 15708262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
